Federal Initiatives Toward Single IRB Review


Federal Initiatives Toward Single IRB Review

Tuesday, February 28
Presentation: 3:00-4:00pm ET
Q&A: 4:00-4:15pm ET


Recent federal initiatives make it clear that the US government favors single IRB review in multisite clinical trials. The NIH sIRB policy, 21st Century Cures Act, the final revised Common Rule and other requirements pose unique challenges as research organizations plan how they will maintain compliance with current and evolving regulations.

In this webinar, Michele Russell-Einhorn, VP of Human Subject Protection Services and Institutional Official at Schulman IRB, discusses recent federal initiatives for single IRB review and their impact on the way sponsors, CROs and institutions conduct research.


  • Describe the recent federal initiatives for single IRB review
  • Explain how these requirements impact the way various stakeholders conduct research
  • Examine ways that research institutions and other organizations relying on local IRB review can work to meet these new rules

Who Should Attend: Investigators, Research Administrators, IRB Members, Clinical Research Managers and Directors, Project Managers, Regulatory Affairs Professionals and others involved in the planning and management of clinical research involving human participants

Certificates of attendance are available for this event. This presentation may qualify for continuing education credits; check with your certifying organization(s) for more information.

Space is limited–register now!